News-Papers
Testimonial
Video Gallery
 | |||||
 |  |  |  |  |  |
Search
Follow us...
Latest
- Radioprotective and Radiomitigative Effects of Melatonin in Tissues with Different Proliferative Activity
- Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)
- Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens
- Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
- The effects of growth hormone on therapy resistance in cancer
- Anti-apoptotic and antioxidant effects of melatonin protect spleen of whole body γ-irradiated male Sprague-dawley rats
- Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Melatonin for the prevention and treatment of cancer
- Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases
- Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
- Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
- Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids
- Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma
- Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
- Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer